A medical system including a compressible device, and a covering over the compressible device, wherein the covering includes a delivery configuration and a deployed configuration, wherein, in the delivery configuration, the covering at least partially covers the compressible device to maintain the compressible device in a compressed state, and wherein, in the deployed configuration, the covering is releasable from the device to transition the compressible device from the compressed state to an expanded state.
|
1. A medical system, comprising:
a compressible device;
a covering over the compressible device, wherein the covering includes a delivery configuration and a deployed configuration,
wherein the covering is a netting; and
a thread or wire coupled to the netting, wherein the thread or the wire is configured to remove the netting via a force applied to the thread or wire,
wherein, in the delivery configuration, the covering at least partially covers the compressible device to maintain the compressible device in a compressed state, and
wherein, in the deployed configuration, the covering is releasable from the device to transition the compressible device from the compressed state to an expanded state.
2. The medical system of
4. The medical system of
5. The medical system of
7. The medical system of
8. The medical system of
9. The medical system of
10. The medical system of
11. The medical system of
14. The medical system of
15. The medical system of
|
This application claims the benefit of priority from U.S. Provisional Application No. 62/982,206, filed on Feb. 27, 2020, which is incorporated by reference herein in its entirety.
This disclosure relates generally to medical treatment systems, devices, and related methods thereof. Embodiments of the disclosure relate to endoluminal wound treatment systems, and medical devices for negative pressure wound therapy.
Endoscopic and open surgical procedures of the gastrointestinal (GI) tract include, for example, colonic resection, bariatric surgery, esophagectomy, gastric bypass, and sleeve gastrectomy, among others. These procedures may result in perforation, post-surgical leaks, or other wounds of the tract. Limited treatment options exist for managing such wounds, which have significant morbidity and mortality rates. Options include surgical re-operation and endoscopic placement of a stent or clips. Surgery is relatively invasive and also has high morbidity and mortality rates. Endoscopic stent placement is a less invasive option. The placed stent, however, can migrate from the intended location and/or wall off infection at the treatment site, inhibiting drainage.
According to an example, a medical system may comprise a compressible device, and a covering over the compressible device, wherein the covering includes a delivery configuration and a deployed configuration, wherein, in the delivery configuration, the covering at least partially covers the compressible device to maintain the compressible device in a compressed state, and wherein, in the deployed configuration, the covering is releasable from the device to transition the compressible device from the compressed state to an expanded state.
In another example, the medical system may further comprise a suction tube, wherein the suction tube is connected to a proximal portion of the compressible device, and the suction tube is configured to apply a suction to the compressible device.
In another example, the compressible device may be porous and absorbent.
In another example, the covering may be a capsule. The capsule may be removable via exposure to a fluid.
In another example, the covering may be a netting. The medical system may further comprise a thread or a wire coupled to the netting, wherein the thread or the wire is configured to remove the netting via a force applied to the thread or the wire. The netting may be configured to be removable when the compressible device pushes against a breaking point of the netting. The netting may be configured to be tightened to further compress the compressible device.
In another example, the covering may be a membrane. The membrane may be impermeable. The membrane may be configured to compress the compressible device via a vacuum seal. The membrane may be removable via exposure to a fluid. The membrane may be configured to be removable when the compressible device pushes against a breaking point of the membrane.
In another example, the covering may completely cover the compressible device.
According to another example, a medical system may comprise a compressible device, a covering over the compressible device, a first tube connected to a proximal portion of the compressible device, and a second tube including a lumen containing the first tube, wherein a proximal end of the lumen is configured to be in communication with a suction source, wherein the covering is fixed to a distal portion of the second tube to contain and seal the compressible device within a cavity of the covering, and the covering is configured to collapse onto the compressible device via a suction supplied to the cavity, thereby compressing the compressible device. The covering may be an impermeable membrane. The compressible device may be configured to compress so that the compressible device fits within the lumen of the second tube. The covering may be configured to be removable from the second tube.
According to another example, a method of endoluminal wound treatment via a medical device, the medical device including a compressible device, a covering over the compressible device, and a tube connected to the compressible device, may comprise positioning the medical device within a cavity of a wound, removing the covering over the compressible device, and providing a suction throughout the compressible device via the tube.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate various exemplary embodiments and together with the description, serve to explain the principles of the disclosed embodiments.
Reference will now be made in detail to aspects of the disclosure, examples of which are illustrated in the accompanying drawings. Wherever possible, the same or similar reference numbers will be used through the drawings to refer to the same or like parts. The term “distal” refers to a portion farthest away from a user when introducing a device into a subject (e.g., patient). By contrast, the term “proximal” refers to a portion closest to the user when placing the device into the subject.
Both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the features, as claimed. As used herein, the terms “comprises,” “comprising,” “having,” “including,” or other variations thereof, are intended to cover a non-exclusive inclusion such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such a process, method, article, or apparatus. In this disclosure, relative terms, such as, for example, “about,” “substantially,” “generally,” and “approximately” are used to indicate a possible variation of ±10% in a stated value or characteristic.
Embodiments of this disclosure include devices, systems, and methods for endoluminal vacuum therapy (EVAC). In examples, EVAC includes endoluminal placement of a sponge or other like material into a wound site, including a perforation, a leak, an anastomosis, etc. Placement of the material may be via a catheter, scope (endoscope, bronchoscope, colonoscope, gastroscope, duodenoscope, etc.), tube, or sheath, inserted into the GI tract via a natural orifice. The orifice can be, for example, the nose, mouth, or anus, and the placement can be in any portion of the GI tract, including the esophagus, stomach, duodenum, large intestine, or small intestine. Placement also can be in other organs reachable via the GI tract. Then, negative pressure may be delivered to the wound site in the GI tract, via a vacuum source.
Furthermore, in embodiments of this disclosure, the sponge of the EVAC devices may be any suitable biocompatible material that may absorb liquids and/or permit liquid to pass therethrough via negative pressure. The material may be flexible, compressible, porous, hydrophilic, sterile, and/or disposable. The sponge material may be an open-cell foam. Suitable materials include polyurethanes, esters, ethers, composite materials, and any medical-grade material.
In the embodiments described below, the compressible sponge is in a compressed state, via varying means and mechanisms, e.g., a covering, a membrane, etc. This is so that the compressed sponge may be more easily deliverable through a working channel of a scope, and through a natural body lumen of a subject. The covering is configured to be releasable or removable in any suitable manner, e.g., sheared, broken, dissolved/degraded, so that the compressed sponge may deploy and expand once delivered to a targeted site.
Referring to
In addition, one or more electrical cables (not shown) may extend from the proximal end of system 5 to the distal end of flexible shaft 50 and may provide electrical controls to imaging, lighting, and/or other electrical devices at the distal end of flexible shaft 50, and may carry imaging signals from the distal end of flexible shaft 50 proximally to be processed and/or displayed on a display. Handle 52 may also include ports 54, 46 for introducing and/or removing tools, fluids, or other materials from the patient. Ports 54 and/or 46 may be used to introduce tools. Ports 54 and/or 46 may also be connected to an umbilicus for introducing fluid, suction, and/or wiring for electronic components. For example, as shown in
As shown in
Referring to
Medical device 10 includes a compressed porous body/sponge 12, as described above, and a capsule covering 14. Sponge 12 may be compressed to an extent so that it, along with capsule 14, may fit within a working channel of any suitable scope and may be deliverable through a natural body lumen of a subject. The manner by which compressed sponge 12 is fit within capsule 14 is not particularly limited, and may be by any suitable manner. For example, sponge 12, after compression, may be inserted into an already formed capsule covering 14. In another example, sponge 12, while compressed, may be coated with a capsule coating which forms capsule covering 14.
Capsule 14 encapsulates compressed sponge 12 in its entirety, but is not limited thereto. In other exemplary embodiments, capsule 14 may cover sponge 12 partially. Capsule 14 may be of any suitable material that may withstand the expandable nature of, and outward forces generated by, compressed sponge 12. In addition, capsule 14 may be of any suitable material configured to dissolve when exposed to fluids of any sort, including fluids having a predetermined pH. Thus, for example, capsule 14 may instantly or gradually dissolve when placed into, and coming into contact with fluids within the body of a subject, via the gastrointestinal tract. Alternatively, capsule 14 may dissolve when capsule 14 is exposed to fluid, e.g., saline, from an external source, via tube 100 or another tool. Suitable materials for capsule 14 include gelatin or other collagen derivatives, hypromellose (HPMC) or other cellulose derivatives, starch, and absorbable polysaccharides. In other exemplary embodiments, capsule 14 may be formed of a suture wrapped to compress the sponge 12, or a mesh material, as described below. The thickness of the layer of capsule 14 is not particularly limited, so long as it allows for both the delivery of device 10 and the deployment of sponge 12. Suitable thicknesses of capsule 14 may be dependent on the material of capsule 14, and may include thicknesses greater than, for example, 100 microns. Thus, device 10 may include a delivery configuration, in which compressed sponge 12 is contained within capsule 14, and a deployed configuration, in which capsule 14 is removed or dissolved and sponge 12 is expanded.
Medical device 10 also includes an opening 16, through which an end of tube 100 may be inserted and thus connected to device 10. Opening 16 extends through both capsule 14 and sponge 12. Opening 16 may be on a proximal end/surface of device 10. Opening 16 may be of any suitable diameter that allows for a secure fit over tube 100. Additionally, opening 16 may be of any suitable depth that also allows for a secure fit over tube 100, while also allowing for a sufficient amount of negative pressure to be distributed throughout device 10 when deployed in a wound. The sponge 12 may be connected to the tube 100 such that the interconnected channels, open cells, or continuous passages in the sponge 12 allow for fluid and materials to be suctioned into the tube 100.
The manner and order in which medical device 10 is formed is not particularly limited. In some exemplary embodiments, opening 16 may be formed in sponge 12, prior to compression of sponge 12, and tube 100 may be inserted into opening 16. Sponge 12 may then be compressed, for example by dehydrating sponge 12 and/or applying suction to sponge 12, to close pores and channels within sponge 12. During or after compression, capsule 14 may be fitted or formed over compressed sponge 12, while accommodating for tube 100. Capsule may be placed over sponge 12 via any suitable method, including coating, e.g., spray coating, dip coating, etc., or wrapping.
Referring to
Medical device 10′, as shown in
Device 10′ further includes a control thread or wire 26 that is coupled to netting 24. Wire 26 is coupled to a proximal portion of netting 24 in
However, device 10′ is not limited to including a control wire 26. In some other exemplary embodiments, device 10′ may be without wire 26, and may include other suitable mechanisms configured to remove netting 24 and deploy sponge 12. For example, netting 24 may include a breaking point, e.g., a stress riser, so that netting 24 may fracture when sponge 12 is advanced and pressed against said breaking point of netting 24. In some exemplary embodiments, such a breaking point may be found on the distal end of netting 24. Alternatively, netting 24 may be severed from sponge 12 via an endoscopic scissor or other tool.
Like device 10, the manner and order in which medical device 10′ is formed is not particularly limited. In some exemplary embodiments, opening 16 may be formed in sponge 12, prior to compression of sponge 12, and tube 100 may be inserted into opening 16. Sponge 12 may then be compressed, for example by application of suction. After compression, netting 24 may be fitted over compressed sponge 12, while accommodating for tube 100. In other exemplary embodiments, netting 24 may be fitted over sponge 12 prior to compression, and netting 24 may be tightened to mechanically compress and contain sponge 12.
Device 10′ may be used in a similar manner as device 10, except a user may transition device 10′ to a deployed configuration by removing netting 24, via wire 26 or any other suitable manner/mechanism.
Medical device 10″, as shown in
Catheter 102 may be connected to a vacuum source so that channel 102a is in fluid communication with cavity 36 formed by membrane 34. To transition device 10″ from a default, expanded configuration to the compressed, delivery configuration, the vacuum source may transmit suction distally, through channel 102a and down to cavity 36 of device 10″. As a result of the suction and impermeable membrane 34 being fixed to catheter 102, membrane 34 collapses onto sponge 12, thereby compressing sponge 12 uniformly, as shown in
The deployed configuration of device 10″ is not particularly limited. For example, when compressed sponge 12 is retracted within channel 102a, as described above, sponge 12 may be extended distally out of catheter 102 to be deployed within the targeted wound. In instances in which membrane 34 is maintained, the distal end of membrane 34 may be slit (e.g. perforated or having a weakened region) so that sponge 12 may be deployed through the slit. In other examples, when device 10″ is maintained in the configuration as shown in
Device 10″ may be used in a similar manner as device 10, except a user may transition device 10″ to a deployed configuration by removing or breaking membrane 34, via the above described manners or mechanisms.
It will be apparent to those skilled in the art that various modifications and variations can be made to the disclosed device without departing from the scope of the disclosure. Other embodiments of the disclosure will be apparent to those skilled in the art from consideration of the specification and practice of the invention disclosed herein. It is intended that the specification and examples be considered as exemplary only, with a true scope and spirit of the invention being indicated by the following claims.
Ryan, Shawn, Raghuram, Ashrita, Sullivan, Kira, Murray, Collin, Favreau, John Thomas, Haugen, Alexandra
Patent | Priority | Assignee | Title |
Patent | Priority | Assignee | Title |
10058413, | Dec 13 2013 | Vac Stent Medtec AG | Suction stent, stent system, and method for sealing a leakage |
10779928, | Dec 13 2013 | Vac Stent Medtec AG | Suction stent, stent system, and method for sealing a leakage |
2057206, | |||
6123697, | Nov 22 1995 | SUMMIT MEDICAL, INC ; SANTA BARBARA MEDCO, INC ; Shippert Enterprises, LLC | Pressure applying fluid transfer method |
20150306287, | |||
20170007752, | |||
20190060609, | |||
20200276056, | |||
DE102008061536, | |||
EP2370036, | |||
EP2394677, | |||
EP3134143, | |||
GB201834, | |||
WO2015164801, | |||
WO2019059893, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Jan 28 2021 | HAUGEN, ALEXANDRA | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 | |
Feb 10 2021 | RAGHURAM, ASHRITA | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 | |
Feb 22 2021 | FAVREAU, JOHN THOMAS | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 | |
Feb 24 2021 | RYAN, SHAWN | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 | |
Feb 25 2021 | MURRAY, COLLIN | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 | |
Feb 26 2021 | Boston Scientific Scimed, Inc. | (assignment on the face of the patent) | / | |||
Mar 10 2021 | SULLIVAN, KIRA | Boston Scientific Scimed, Inc | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 055876 | /0072 |
Date | Maintenance Fee Events |
Feb 26 2021 | BIG: Entity status set to Undiscounted (note the period is included in the code). |
Date | Maintenance Schedule |
Feb 21 2026 | 4 years fee payment window open |
Aug 21 2026 | 6 months grace period start (w surcharge) |
Feb 21 2027 | patent expiry (for year 4) |
Feb 21 2029 | 2 years to revive unintentionally abandoned end. (for year 4) |
Feb 21 2030 | 8 years fee payment window open |
Aug 21 2030 | 6 months grace period start (w surcharge) |
Feb 21 2031 | patent expiry (for year 8) |
Feb 21 2033 | 2 years to revive unintentionally abandoned end. (for year 8) |
Feb 21 2034 | 12 years fee payment window open |
Aug 21 2034 | 6 months grace period start (w surcharge) |
Feb 21 2035 | patent expiry (for year 12) |
Feb 21 2037 | 2 years to revive unintentionally abandoned end. (for year 12) |